2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Bronchial Tumors
Bronchial tumors, a subset of lung cancer, present a formidable challenge in cancer research due to their intricate nature and often delayed detection. Investigative efforts span diverse fronts, seeking deeper insights into their molecular intricacies to devise more efficacious treatments. Innovations in diagnostic imaging facilitate early identification, amplifying prospects for patient survival. Moreover, immunotherapy emerges as a beacon of hope, leveraging the body's immune prowess to selectively combat cancer cells. Tailoring therapies based on individual genetic makeup, known as precision medicine, holds significant promise in optimizing treatment outcomes. Multidisciplinary collaborations among oncologists, genetic specialists, and immunologists are pivotal in advancing understanding and crafting groundbreaking interventions against bronchial tumors. Continued research endeavors foster optimism for bolstered survival rates and enhanced well-being among those grappling with this formidable cancer variant.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China